China’s Everest starts first phase operations to make mRNA vaccines
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.